The Ministry of Health (MOH) is speeding up efforts to draft management regulations for accepting donations and financial sponsorships by medical institutions, according to Mao Qun'an, director of the Anti-bribery Office under MOH recently during the Anti Commercial Bribery Summit Forum.

The regulations aim to set a clear boundary between accepting donations and business bribes so as to effectively curb currently rampant commercial bribes in the medicine circulation chain.

Mao confirmed that pharmaceutical firms are welcome to sponsor medical institutions and academic organizations in accordance with related standards, and sponsor activities shall be carried out in a standardized and open manner.

Mao disclosed a few detailed measures the MOH is working on, which mainly include establishing a blacklist system, formulating management measures for donation acceptance and regulations for doctors' compulsory use of pharmaceutical names for prescriptions instead of brand names.

......

The full text is available in the September Issue of China Medicine.

(For more biz stories, please visit Industry Updates)